Multiple Tumours

Gene: PIK3CA

Amber List (moderate evidence)

PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha)
EnsemblGeneIds (GRCh38): ENSG00000121879
EnsemblGeneIds (GRCh37): ENSG00000121879
OMIM: 171834, Gene2Phenotype
PIK3CA is in 22 panels

1 review

Ellen McDonagh (Genomics England Curator)

Comment on list classification: On the UKGTN Hereditary Cancers 82 Gene Panel, Familia Breast/Ovarian Cancer subsection. Seems to be somatic?
Created: 18 Apr 2017, 1:32 p.m.

Mode of inheritance
Unknown

Phenotypes
Breast cancer, somatic 114480; CLOVE syndrome, somatic 612918; Colorectal cancer, somatic 114500; Cowden syndrome 5 615108; Gastric cancer, somatic 613659; Hepatocellular carcinoma, somatic 114550; Keratosis, seborrheic, somatic 182000; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic 602501; Nevus, epidermal, somatic 162900; Nonsmall cell lung cancer, somatic 211980; Ovarian cancer, somatic 167000

Details

Mode of Inheritance
Unknown
Sources
  • Expert Review Amber
  • UKGTN
Phenotypes
  • Breast cancer, somatic 114480
  • CLOVE syndrome, somatic 612918
  • Colorectal cancer, somatic 114500
  • Cowden syndrome 5 615108
  • Gastric cancer, somatic 613659
  • Hepatocellular carcinoma, somatic 114550
  • Keratosis, seborrheic, somatic 182000
  • Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic 602501
  • Nevus, epidermal, somatic 162900
  • Nonsmall cell lung cancer, somatic 211980
  • Ovarian cancer, somatic 167000
OMIM
171834
Clinvar variants
Variants in PIK3CA
Penetrance
Complete
Panels with this gene

History Filter Activity

18 Apr 2017, Gel status: 2

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Amber List (Moderate Evidence).

18 Apr 2017, Gel status: 0

Created

Ellen McDonagh (Genomics England Curator)

PIK3CA was created by ellenmcdonagh

18 Apr 2017, Gel status: 1

Added New Source

Ellen McDonagh (Genomics England Curator)

PIK3CA was added to Multiple Tumourspanel. Sources: UKGTN